medicina58巻4号

2021年04月発行

増刊号 救急診療　好手と悪手 循環器系

心房細動，上室性頻拍—救急外来から患者に寄り添う不整脈治療を始めよう

著者： 井上敦人¹ 溝辺倫子¹

所属機関： ¹東京ベイ浦安・市川医療センター救急集中治療科

ページ範囲：P.78 - P.82

こんな対応は悪手
①とりあえずワソラン^®（ベラパミル塩酸塩）
②診断後，すぐに不整脈治療開始
③rhythm control（洞調律復帰）を目指す
④帰って安静にしていれば大丈夫
⑤高齢だから抗凝固療法を行わない

参考文献

1）日本循環器学会，他：2020年改訂版 不整脈薬物治療ガイドライン，2020　https://www.j-circ.or.jp/cms/wp-content/uploads/2020/01/JCS2020_Ono.pdf（2020年12月閲覧）

2）Appelboam A, et al：Postural modification to the standard Valsalva manoeuvre for emergency treatment of supraventricular tachycardias（REVERT）；A randomised controlled trial. Lancet 386：1747-1753, 2015

3）January CT, et al：2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation；Executive summary；A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation 130：2071-2104, 2014

4）Chugh SS, et al：Worldwide epidemiology of atrial fibrillation；A Global Burden of Disease 2010 Study. Circulation 129：837-847, 2014

5）Liu G, et al：Meta-analysis of nonsteroidal anti-inflammatory drug use and risk of atrial fibrillation. Am J Cardiol 114：1523-1529, 2014

6）Wyse DG, et al：A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 347：1825-1833, 2002

7）Van Gelder IC, et al：A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 347：1834-1840, 2002

8）Roy D, et al：Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358：2667-2677, 2008

9）Hindricks G, et al：2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery（EACTS）. Eur Heart J：ehaa612, 2020, Online ahead of print

10）Arnold AZ, et al：Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 19：851-855, 1992

11）Naccarelli GV, et al：Cost-effective management of acute atrial fibrillation；Role of rate control, spontaneous conversion, medical and direct current cardioversion, transesophageal echocardiography, and antiembolic therapy. Am J Cardiol 85：36D-45D,2000

12）Marrouche NF, et al：Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 378：417-427, 2018

13）Mark DB, et al：Effect of catheter ablation vs medical therapy on quality of life among patients with atrial fibrillation；The CABANA Randomized Clinical Trial. JAMA 321：1275-1285, 2019

14）Berruezo A, et al：Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 28：836-841, 2007

15）Nguyen TN, et al：The impact of frailty on mortality, length of stay and re-hospitalisation in older patients with atrial fibrillation.Heart Lung Circ 25：551-557, 2016

16）Yamashita Y, et al：Clinical characteristics and outcomes in extreme elderly（Age ≥ 85 Years）Japanese patients with atrial fibrillation；The Fushimi AF Registry. Chest 149：401-412, 2016

17）Olesen JB, et al：Validation of risk stratificationschemes for predicting stroke and thromboembo-lism in patients with atrial fi brillation；Nationwidecohort study. BMJ 342：d124, 2011